Differences in presentation and follow-up between HIV-1 antibody positive teenagers and adults

Katia Prime(Lothian Sexual Health), Simon Edwards(Mortimer Market Centre), Annemiek de Ruiter(ViiV Healthcare (Spain)), Emma Fox(St George's Hospital), Chris Taylor(European Bioinformatics Institute), Caroline Sabin(Primary Health Care), G Sethi(Brighton Hospital), Leslie Navaratne(St Thomas' Hospital), Gill Dean(Royal Sussex County Hospital), Graham D. Taylor(St Mary's Hospital)

AIDS

January 1, 2003

10.1097/00002030-200301240-00018

Cited by 5

Related Papers

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

|AIDS|2003|987

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

|The Lancet|2014|930

Targeting C-reactive protein for the treatment of cardiovascular disease

|Nature|2006|676

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

|The Journal of Infectious Diseases|2009|649

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

|The Lancet|1996|631